We are live on ! Find out more
TCM

Tang Capital Management Portfolio holdings

AUM $1.97B
1-Year Est. Return 125.1%
This Fund
S&P 500
This Quarter Est. Return
+40.53%
1 Year Est. Return
+125.1%
3 Year Est. Return
+474.48%
5 Year Est. Return
+595.08%
10 Year Est. Return
+2,831.44%
AUM
$277M
AUM Growth
+$89.2M
Cap. Flow
+$40.8M
Cap. Flow %
14.73%
Top 10 Hldgs %
100%
Holding
6
New
Increased
3
Reduced
Closed
1

Top Sells

Rank Stock Value
1
ATYR
aTyr Pharma
ATYR
+$601K

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HRTX icon
1
Heron Therapeutics
HRTX
$86.3M
$130M 46.92%
8,654,914
+2,457,716
+40% +$34M
LJPC
2
DELISTED
La Jolla Pharmaceutical Company
LJPC
$103M 37.12%
3,440,419
+249,254
+8% +$6.36M
RXDX
3
DELISTED
Ignyta, Inc.
RXDX
$34.2M 12.35%
3,972,800
BMRN icon
4
BioMarin Pharmaceuticals
BMRN
$11.5B
$7.92M 2.86%
90,215
BGMS
5
Bio Green Med Solution Inc
BGMS
$5.05M
$2.06M 0.74%
8
+3
+60% +$983K
ATYR
6
aTyr Pharma
ATYR
$46.4M
-19,959
Closed -$601K

Similar funds

Tang Capital Management's Q1 2017 Portfolio in Review

As of Q1 2017, Tang Capital Management held 6 positions worth $277M, up 48% from $188M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Tang Capital Management deployed $40.8M of net new capital in Q1 2017, adding to 3 existing holdings.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 90% a quarter earlier.

On the sell side, the most notable exit was aTyr Pharma, an estimated $601K sold.

  • Tang Capital Management added most to Heron Therapeutics in Q1 2017, an estimated $34M increase.
  • Tang Capital Management fully exited aTyr Pharma in Q1 2017, selling an estimated $601K.
  • Tang Capital Management's ten largest holdings make up 100% of its $277M portfolio in Q1 2017.
  • Tang Capital Management opened 0 new positions and closed 1 in Q1 2017.
  • Tang Capital Management's portfolio value rose 48% quarter-over-quarter to $277M.

Based on Tang Capital Management's 13F filing for Q1 2017, filed 15 May 2017.